Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 124 of 151

  1. TAK-583

    Takeda

    Diabetic Neuropathies

    phase 2 small molecule completed

    1 trial

  2. TAK-653

    Takeda

    Treatment-Resistant Depression

    phase 2 small molecule terminated

    1 trial

  3. TAK-659

    Takeda

    AML

    phase 2 small molecule terminated

    1 trial

  4. TAK-662

    Takeda

    Congenital Protein C Deficiency

    phase 2 small molecule completed

    1 trial

  5. TAK-676-1002

    Takeda

    Solid Neoplasm

    phase 2 small molecule active

    1 trial

  6. TAK-700

    Takeda

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  7. TAK-715 and methotrexate

    Takeda

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  8. TAK-755

    Takeda

    Acute Ischemic Stroke

    phase 2 mab active

    1 trial

  9. TAK-755-2001

    Takeda

    Immune-mediated thrombotic thrombocytopenic purpura (iTTP)

    phase 2 small molecule active

    1 trial

  10. TAK-783 and methotrexate

    Takeda

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  11. TAK-788

    Takeda

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule active

    1 trial

  12. TAK-788

    Takeda

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule terminated

    1 trial

  13. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Friedreich Ataxia

    phase 2 small molecule completed

    1 trial

  14. TAK-850

    Takeda

    Influenza

    phase 2 small molecule completed

    1 trial

  15. TAK-850

    Takeda

    Influenza Infection

    phase 2 mab completed

    1 trial

  16. TAK-850

    Takeda

    Influenza Prevention

    phase 2 small molecule terminated

    1 trial

  17. TAK-850 0.5 mL injection

    Takeda

    Influenza Infection

    phase 2 small molecule completed

    1 trial

  18. TAK-853

    Takeda

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  19. TAK-906 Maleate

    Takeda

    Diabetic Gastroparesis

    phase 2 small molecule completed

    1 trial

  20. TAK-906 Maleate

    Takeda

    Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis

    phase 2 small molecule completed

    1 trial

  21. TAK-919

    Takeda

    Coronavirus Disease (COVID-19)

    phase 2 mab completed

    1 trial

  22. TAK-931

    Takeda

    Metastatic Pancreatic Cancer

    phase 2 small molecule completed

    1 trial

  23. TAK-935

    Takeda

    Developmental and/or Epileptic Encephalopathies

    phase 2 small molecule completed

    1 trial

  24. TAK-935

    Takeda

    Epilepsy

    phase 2 small molecule completed

    2 trials

  25. TAK-951

    Takeda

    Postoperative Nausea and Vomiting (PONV)

    phase 2 small molecule completed

    1 trial

  26. TAK-954

    Takeda

    Diabetic Gastroparesis

    phase 2 small molecule completed

    1 trial

  27. TAK-954

    Takeda

    Critical Illness

    phase 2 small molecule terminated

    1 trial

  28. TAK-954 Placebo

    Takeda

    Postoperative Gastrointestinal Dysfunction

    phase 2 small molecule completed

    1 trial

  29. TAK-981

    Takeda

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 2 small molecule terminated

    1 trial

  30. TAK-981

    Takeda

    Lymphoma, Non-Hodgkin

    phase 2 small molecule terminated

    1 trial

  31. TAK-981

    Takeda

    Neoplasms

    phase 2 small molecule terminated

    1 trial

  32. TAK-981

    Takeda

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule completed

    1 trial

  33. TAK-994

    Takeda

    Narcolepsy Type 1 (NT 1)

    phase 2 small molecule terminated

    1 trial

  34. TAK-994

    Takeda

    Narcolepsy Type 1 (NT1)

    phase 2 small molecule terminated

    1 trial

  35. TAK228

    Takeda

    Lymphoma

    phase 2 small molecule terminated

    1 trial

  36. TAMOXENE 20 mg compresse rivestite con film

    Verona Pharma Ireland Limited

    cystic fibrosis

    phase 2 small molecule active

    1 trial

  37. TAR-0520 Gel

    Lacuna Pharma Pty Ltd

    Capecitabine-induced hand and foot syndrome

    phase 2 small molecule active

    1 trial

  38. TAR-0520 Gel

    Lacuna Pharma Pty Ltd

    Taxanes-induced peripheral neuropathy

    phase 2 small molecule active

    1 trial

  39. TARA-002

    Protara Therapeutics

    Non-muscle Invasive Bladder Cancer

    phase 2 mab active

    3 trials

  40. TARA-002

    Protara Therapeutics

    Lymphatic Malformation

    phase 2 mab active

    1 trial

  41. TARIAN 007

    Lacuna Pharma Pty Ltd

    EGFR inhibitor-induced folliculitis

    phase 2 small molecule active

    1 trial

  42. TAS-120

    Taiho Pharma Netherlands B.V.

    Advanced Cholangiocarcinoma

    phase 2 small molecule active

    1 trial

  43. TAS-120-203

    Taiho Pharma Netherlands B.V.

    Advanced or Metastatic Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  44. TAS-120-206

    Taiho Pharma Netherlands B.V.

    Solid Tumors

    phase 2 small molecule active

    1 trial

  45. TAS-205

    Taiho Pharma Netherlands B.V.

    Duchenne Muscular Dystrophy

    phase 2 small molecule completed

    1 trial

  46. TAS-303

    Taiho Pharma Netherlands B.V.

    Stress Urinary Incontinence

    phase 2 small molecule completed

    1 trial

  47. TAVR

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aortic Valve Disease

    phase 2 other active

    1 trial

  48. TAX625

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.